Indications
Prevention of rotavirus gastroenteritis in children up to 24 months of age
PDF page 543
Drug reference
Prevention of rotavirus gastroenteritis in children up to 24 months of age
PDF page 543
Do not administer in case of: acute gastroenteritis, history of intussusception, severe immunodeficiency; allergic reactions to a previous dose of vaccine. Vaccination should be postponed in the event of severe acute febrile illness; minor infections are not contra-indications. May cause: rarely: intussusception, anaphylactic reactions. If the child regurgitates/spits out/vomits the vaccine immediately after administration, wait a few minutes and re-administer the same dose.
PDF pages 543, 544
Oral suspension, in monodose plastic tube: Rotarix®, 1.5 ml tube, live-attenuated monovalent human rotavirus vaccine (RV1, strain RIX4414) Rotasiil®, 2 ml tube, live-attenuated pentavalent human-bovine reassortant rotavirus vaccine (RV5, G1, G2, G3, G4 and G9) Rotateq®, 2 ml tube, live-attenuated pentavalent human-bovine reassortant rotavirus vaccine (RV5, G1, G2, G3, G4 and P1A[8]) DO NOT ADMINISTER BY PARENTERAL ROUTE.
PDF page 543
Child 6 weeks to 24 months: Depending on the available vaccine, 2 to 3 doses at least 4 weeks apart Shake the plastic tube, squeeze the entire content of the tube into the mouth. Recommended schedule: Age Vaccine 6 weeks 10 weeks 14 weeks Rotarix® Dose 1 Dose 2 Rotasiil®, Rotateq® Dose 1 Dose 2 Dose 3
PDF page 543
Other rotavirus vaccines may be available (e.g. Rotavac®). The vaccination should be completed with the same vaccine when feasible. If not possible, follow national and manufacturer recommendations. Rotavirus vaccine can be administered concomitantly with other vaccines recommended in childhood.
PDF page 544
– Between 2 °C and 8 °C. Do not freeze. Once opened, the content must be administered immediately; discard any unused open tube.
PDF page 544